Senna-S

Product NDC
60258-951
11-digit product format
602580951
Labeler code
60258
Product ID
60258-951_38e18992-4444-47d4-baf8-090a545fff22
Type
HUMAN OTC DRUG
Nonproprietary name
Docusate Sodium and Sennosides
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Cypress Pharmaceutical, Inc.
Application
part334
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2002-05-03
Marketing end
0000-00-00
Substance
SENNOSIDES; DOCUSATE SODIUM
Active strength
9 mg/1; mg/1
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct60258-951DDiscontinued by firm2026-10-12
excluded packagepackage60258-95160258-951-06DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage60258-951-06d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage60258-951-06f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage60258-951-062ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage60258-951-06a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage60258-951-06cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage60258-951-06cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage60258-951-06302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage60258-951-06ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage60258-951-060efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage60258-951-06ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage60258-951-06367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage60258-951-06557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60258-951-06EA - Each60258-95157c7bc73-3c8d-4c0d-ba8e-ded98cc0b4c012015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Docusate SodiumACTIVE INGREDIENTF05Q2T2JA0SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
SennosidesACTIVE INGREDIENT3FYP5M0IJXSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
DocusateACTIVE MOIETYM7P27195AGSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
SennosidesACTIVE MOIETY3FYP5M0IJXSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Calcium Phosphate, Dibasic, AnhydrousINACTIVE INGREDIENTL11K75P92JSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Cellulose, MicrocrystallineINACTIVE INGREDIENTOP1R32D61USENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Croscarmellose SodiumINACTIVE INGREDIENTM28OL1HH48SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
D&C Yellow No. 10INACTIVE INGREDIENT35SW5USQ3GSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
DextroseINACTIVE INGREDIENTIY9XDZ35W2SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
FD&C Yellow No. 6INACTIVE INGREDIENTH77VEI93A8SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
HypromellosesINACTIVE INGREDIENT3NXW29V3WOSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Magnesium StearateINACTIVE INGREDIENT70097M6I30SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Polyethylene GlycolsINACTIVE INGREDIENT3WJQ0SDW1ASENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Silicon DioxideINACTIVE INGREDIENTETJ7Z6XBU4SENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Sodium BenzoateINACTIVE INGREDIENTOJ245FE5EUSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Stearic AcidINACTIVE INGREDIENT4ELV7Z65APSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2
Titanium DioxideINACTIVE INGREDIENT15FIX9V2JPSENNA-S (DOCUSATE SODIUM AND SENNOSIDES) TABLET, FILM COATED [CYPRESS PHARMACEUTICAL, INC.]2

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
60258-951-066025809510660 TABLET, FILM COATED in 1 BOTTLE (60258-951-06) 2002-05-030000-00-00NoNoCurrent